Skip to search formSkip to main contentSkip to account menu

NA-LMWH

Known as: non-anticoagulant oxidized ultra-LMWH 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
This study aimed to observe the safety and effectiveness of different dosing regimens of low molecular weight heparin in the… 
2013
2013
Přispěvek je zaměřen na problematiku aplikace nizkomolekularnich heparinů v Ceske republice, protože v klinicke praxi je uživano… 
2006
2006
Summary The use of heparin as the most potent anticoagulant for the prevention of deep vein thrombosis and pulmonary embolism is… 
2004
2004
SummaryThe antithromboembolic efficacy of once a day low molecular weight heparin in fixed combination with dihydroergotamine… 
2000
2000
t Background:: The reported incidence of a subsequen t diagnosi s of malignancy in patientss presenting with deep vein thrombosi… 
Review
1998
Review
1998
In the last 12 months, the Food and Drug Administration issued two documents warning the medical profession about the concurrent… 
1990
1990
In einer offenen, randomisierten, kontrollierten und prospektiven Studie wurden LMWH und unfraktioniertes Heparin (UFH…